The serotonergic system in Parkinson's disease
- 31 October 2011
- journal article
- review article
- Published by Elsevier BV in Progress in Neurobiology
- Vol. 95 (2), 163-212
- https://doi.org/10.1016/j.pneurobio.2011.08.004
Abstract
No abstract availableKeywords
This publication has 865 references indexed in Scilit:
- Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease PsychosisArchives of Neurology, 2011
- Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian ratsExperimental Neurology, 2011
- The neurotransmitter serotonin interrupts α-synuclein amyloid maturationBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- The role of the dorsal raphe nucleus in the development, expression, and treatment of L‐dopa‐induced dyskinesia in hemiparkinsonian ratsSynapse, 2009
- The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanismPsychopharmacology, 2009
- Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian ratNeuropharmacology, 2008
- Contribution of the striatum to the effects of 5‐HT1A receptor stimulation in L‐DOPA‐treated hemiparkinsonian ratsJournal of Neuroscience Research, 2008
- Loss of thalamic serotonin transporters in early drug-naïve Parkinson’s disease patients is associated with tremor: an [123I]β-CIT SPECT studyJournal of Neural Transmission, 2008
- Placebo influences on dyskinesia in Parkinson's diseaseMovement Disorders, 2008
- Editing of the serotonin 2C receptor pre-mRNA: Effects of the Morris Water MazeGene, 2007